Stacie B Dusetzina

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 21:1251-60. 2012
  2. pmc Treatment use and costs among privately insured youths with diagnoses of bipolar disorder
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 63:1019-25. 2012
  3. doi Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Pharmacotherapy 32:1085-94. 2012
  4. pmc Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 64:83-7. 2013
  5. doi Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Psychiatr Serv 62:1443-9. 2011
  6. pmc High-risk medication use by nursing home residents before and after hospitalization
    David G Stevenson
    Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, Department of Health Policy and Management, Gillings School of Global Public, University of North Carolina at Chapel Hill, Chapel Hill, NC The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH Hebrew Senior Life, Institute for Aging Research, Boston, MA Omnicare Inc, Livonia, MI Department of Health Care Policy, Harvard Medical School Department of Health Policy and Management, Harvard School of Public Health, Boston Harvard Kennedy School, Cambridge National Bureau of Economic Research, Cambridge, MA
    Med Care 52:884-90. 2014
  7. ncbi Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia
    Aaron N Winn
    Aaron N Winn and Stacie B Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill, NC and Nancy L Keating, Harvard Medical School and Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 34:4323-4328. 2016
  8. doi Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia
    Stacie B Dusetzina
    Stacie B Dusetzina, School of Medicine and Lineberger Comprehensive Cancer Center and Cecil G Sheps Center for Health Services Research Stacie B Dusetzina and Aaron N Winn, Gillings School of Global Public Health University of North Carolina at Chapel Hill, Chapel Hill, NC Gregory A Abel, Dana Farber Cancer Institute Haiden A Huskamp and Nancy L Keating, Harvard Medical School and Nancy L Keating, Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 32:306-11. 2014
  9. pmc Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Med Care 50:466-78. 2012
  10. pmc Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods
    Lydia E Pace
    Department of Internal Medicine, Division of Women s Health, Brigham and Women s Hospital, Boston, MA Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC Department of Internal Medicine, Division of General Internal Medicine, Brigham and Women s Hospital Department of Health Care Policy, Harvard Medical School, Boston, MA
    Med Care 54:811-7. 2016

Detail Information

Publications12

  1. pmc Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 21:1251-60. 2012
    ..We examine subsequent changes in incident and prevalent SGA use among individuals with severe mental illness...
  2. pmc Treatment use and costs among privately insured youths with diagnoses of bipolar disorder
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 63:1019-25. 2012
    ..The objectives of the study were to identify one-year health services utilization and treatment costs among youths newly diagnosed as having bipolar disorder...
  3. doi Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Pharmacotherapy 32:1085-94. 2012
    ..To estimate the treated prevalence of bipolar disorder in a privately insured population, describe the characteristics of children and adolescents receiving these diagnoses, and describe patterns of their psychotropic drug therapy...
  4. pmc Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 64:83-7. 2013
    ..S. Food and Drug Administration (FDA) communication and consensus statement warning of the drug's increased metabolic risks, but whether declines differed by racial-ethnic groups is unknown...
  5. doi Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Psychiatr Serv 62:1443-9. 2011
    ..This study examined the extent to which children with bipolar I disorder received recommended treatment of mood-stabilizer or second-generation antipsychotic monotherapy and factors associated with its receipt...
  6. pmc High-risk medication use by nursing home residents before and after hospitalization
    David G Stevenson
    Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, Department of Health Policy and Management, Gillings School of Global Public, University of North Carolina at Chapel Hill, Chapel Hill, NC The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH Hebrew Senior Life, Institute for Aging Research, Boston, MA Omnicare Inc, Livonia, MI Department of Health Care Policy, Harvard Medical School Department of Health Policy and Management, Harvard School of Public Health, Boston Harvard Kennedy School, Cambridge National Bureau of Economic Research, Cambridge, MA
    Med Care 52:884-90. 2014
    ..Research about prescribing practices at this important clinical juncture is limited...
  7. ncbi Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia
    Aaron N Winn
    Aaron N Winn and Stacie B Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill, NC and Nancy L Keating, Harvard Medical School and Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 34:4323-4328. 2016
    ..Delayed initiation among individuals without cost-sharing subsidies suggests that out-of-pocket costs may be a barrier to timely initiation of therapy among individuals diagnosed with CML...
  8. doi Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia
    Stacie B Dusetzina
    Stacie B Dusetzina, School of Medicine and Lineberger Comprehensive Cancer Center and Cecil G Sheps Center for Health Services Research Stacie B Dusetzina and Aaron N Winn, Gillings School of Global Public Health University of North Carolina at Chapel Hill, Chapel Hill, NC Gregory A Abel, Dana Farber Cancer Institute Haiden A Huskamp and Nancy L Keating, Harvard Medical School and Nancy L Keating, Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 32:306-11. 2014
    ..We examined trends in imatinib expenditures from 2002 to 2011 and assessed the association between copayment requirements for imatinib and TKI adherence...
  9. pmc Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Med Care 50:466-78. 2012
    ..To review literature on the impact of The Food and Drug Administration (FDA) drug risk communications on medication utilization, health care services use, and health outcomes...
  10. pmc Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods
    Lydia E Pace
    Department of Internal Medicine, Division of Women s Health, Brigham and Women s Hospital, Boston, MA Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC Department of Internal Medicine, Division of General Internal Medicine, Brigham and Women s Hospital Department of Health Care Policy, Harvard Medical School, Boston, MA
    Med Care 54:811-7. 2016
    ..Whether the ACA's mandate has impacted long-acting reversible contraceptives (LARC) use is unknown...
  11. pmc Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy
    Stacie B Dusetzina
    Stacie B Dusetzina, University of North Carolina Eshelman School of Pharmacy, Gillings School of Global Public Health, and Lineberger Comprehensive Cancer Center and Cecil G Sheps Center for Health Services Research, Chapel Hill, NC and Nancy L Keating, Harvard Medical School and Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 34:375-80. 2016
    ..How much these changes will reduce out-of-pocket costs is unclear...
  12. pmc Medicare Part D plan generosity and medication use among dual-eligible nursing home residents
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, Boston, MA The Dartmouth Institute and Geisel Medical School at Dartmouth, Lebanon, NH Division of General Medicine and Clinical Epidemiology, School of Medicine Department of Health Policy and Management, Gillings School of Global Public Health Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC Institute for Aging Research, Hebrew SeniorLife, Deaconess Medical Center Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA Omnicare Inc, Livonia, MI Department of Health Policy and Management, Harvard School of Public Health, Boston Harvard Kennedy School, Cambridge, MA
    Med Care 51:894-900. 2013
    ..Therefore, residents' assigned plans may be relatively more or less generous for their particular drugs. The impact of generosity on residents' medication use and health outcomes is unknown...